Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Effects of Romantic Affection on Blood Chemistry and Immune Parameters
This study has been completed.
Sponsors and Collaborators: Arizona State University
National Institute of Mental Health (NIMH)
Information provided by: Arizona State University
ClinicalTrials.gov Identifier: NCT00482404
  Purpose

This trial tests the hypothesis that increasing nonverbal affection in romantic relationships will improve blood lipid parameters (total cholesterol, high and low density lipoproteins, triglycerides), blood glucose, and immune parameters (C-reactive protein and antibodies to latent Epstein-Barr virus). 52 healthy cohabiting romantic couples took part. In half of the couples, one partner increased the frequency of romantic kissing with the other partner during the six-week trial. The other couples received no such instruction. Blood tests performed before and after the trial were used to assess the health outcomes.


Condition Intervention Phase
Stress
Hypercholesterolemia
Behavioral: Romantic kissing
Phase 0

Genetics Home Reference related topics: hypercholesterolemia
MedlinePlus related topics: Cholesterol
Drug Information available for: Immunoglobulins Globulin, Immune Dextrose Lipids
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind, Placebo Control, Parallel Assignment
Official Title: Study of the Effects of Romantic Affection on Blood Lipids, Blood Glucose, C-Reactive Protein, and Antibodies to Latent Epstein-Barr Virus

Further study details as provided by Arizona State University:

Study Start Date: February 2007
Study Completion Date: May 2007
  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • 18+ years of age;
  • English-speaking;
  • Current co-habitation with romantic partner

Exclusion Criteria:

  • History of hypercholesterolemia;
  • Current pregnancy;
  • Current use of blood-thinning agents;
  • Greater than moderate anxiety about giving capillary blood;
  • Weight of less than 110 pounds
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00482404

Sponsors and Collaborators
Arizona State University
Investigators
Principal Investigator: Kory Floyd, PhD Arizona State University
  More Information

Study ID Numbers: 1001 R03 MH075757-01A1
Study First Received: June 4, 2007
Last Updated: June 4, 2007
ClinicalTrials.gov Identifier: NCT00482404  
Health Authority: United States: Institutional Review Board

Study placed in the following topic categories:
Virus Diseases
Antibodies
Metabolic Diseases
Hyperlipidemias
Stress
Metabolic disorder
Hypercholesterolemia
Dyslipidemias
Immunoglobulins
Lipid Metabolism Disorders

ClinicalTrials.gov processed this record on January 14, 2009